drugset / Trial / NCT05847517
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
Phase 3
Terminated
14 enrolled
Biomedical Research Networking Center (CIBER)
European Commission · collabInstituto de Salud Carlos III · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy of intravenous metoprolol in patients with Acute Respiratory Respiratory Distress Syndrome (ARDS).
Timeline
- Start
- 2024-07-10
- Primary completion
- 2025-10-06
- Completion
- 2025-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoprolol | Other / unclassified | 15 mg | Intravenous |